Elena Polycarpou

806 total citations
23 papers, 609 citations indexed

About

Elena Polycarpou is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Pharmaceutical Science. According to data from OpenAlex, Elena Polycarpou has authored 23 papers receiving a total of 609 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 5 papers in Pulmonary and Respiratory Medicine and 5 papers in Pharmaceutical Science. Recurrent topics in Elena Polycarpou's work include Neonatal Respiratory Health Research (5 papers), Advanced Drug Delivery Systems (4 papers) and Nanoparticle-Based Drug Delivery (3 papers). Elena Polycarpou is often cited by papers focused on Neonatal Respiratory Health Research (5 papers), Advanced Drug Delivery Systems (4 papers) and Nanoparticle-Based Drug Delivery (3 papers). Elena Polycarpou collaborates with scholars based in United Kingdom, Greece and Egypt. Elena Polycarpou's co-authors include Peter J.S. Foot, G Calabrese, Lambros Lambrinos, Eftychios Protopapadakis, Maha Nasr, Omaima A. Sammour, Rasha T.A. Abdel-Aziz, Wael Mamdouh, Simon Carrington and Ali Ryan and has published in prestigious journals such as PLoS ONE, Biochemical Journal and International Journal of Molecular Sciences.

In The Last Decade

Elena Polycarpou

23 papers receiving 598 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elena Polycarpou United Kingdom 14 163 98 77 67 64 23 609
Mahdi Zeinali Iran 13 181 1.1× 139 1.4× 184 2.4× 117 1.7× 9 0.1× 15 845
Wei Hsum Yap Malaysia 16 600 3.7× 68 0.7× 57 0.7× 72 1.1× 11 0.2× 47 1.3k
Hongxia Zhu China 19 154 0.9× 47 0.5× 102 1.3× 63 0.9× 12 0.2× 49 656
Xuebo Li China 19 317 1.9× 154 1.6× 69 0.9× 84 1.3× 6 0.1× 63 979
Zhuxian Wang China 18 171 1.0× 46 0.5× 133 1.7× 49 0.7× 13 0.2× 49 697
Mengting Zhou China 16 407 2.5× 103 1.1× 15 0.2× 70 1.0× 21 0.3× 64 988
Cătălina Bogdan Romania 18 86 0.5× 164 1.7× 164 2.1× 71 1.1× 6 0.1× 38 771
Songzhi Kong China 21 302 1.9× 244 2.5× 57 0.7× 99 1.5× 14 0.2× 31 1.1k
Abhishek Arya India 17 121 0.7× 170 1.7× 109 1.4× 128 1.9× 24 0.4× 35 790
Wandee Rungseevijitprapa Thailand 12 78 0.5× 54 0.6× 172 2.2× 40 0.6× 15 0.2× 24 540

Countries citing papers authored by Elena Polycarpou

Since Specialization
Citations

This map shows the geographic impact of Elena Polycarpou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elena Polycarpou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elena Polycarpou more than expected).

Fields of papers citing papers by Elena Polycarpou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elena Polycarpou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elena Polycarpou. The network helps show where Elena Polycarpou may publish in the future.

Co-authorship network of co-authors of Elena Polycarpou

This figure shows the co-authorship network connecting the top 25 collaborators of Elena Polycarpou. A scholar is included among the top collaborators of Elena Polycarpou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elena Polycarpou. Elena Polycarpou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Foot, Peter J.S., et al.. (2021). Overcoming the protein corona in chitosan-based nanoparticles. Drug Discovery Today. 26(8). 1825–1840. 28 indexed citations
2.
Polycarpou, Elena, et al.. (2021). Efficacy of cannabinoids against glioblastoma multiforme: A systematic review. Phytomedicine. 88. 153533–153533. 12 indexed citations
3.
Mamdouh, Wael, Maha Nasr, Amr ElShaer, et al.. (2021). Quercetin loaded cosm-nutraceutical electrospun composite nanofibers for acne alleviation: Preparation, characterization and experimental clinical appraisal. International Journal of Pharmaceutics. 612. 121309–121309. 37 indexed citations
4.
Lawton, Scott P., et al.. (2021). Cocaine Induces Cytoskeletal Changes in Cardiac Myocytes: Implications for Cardiac Morphology. International Journal of Molecular Sciences. 22(5). 2263–2263. 3 indexed citations
5.
Nasr, Maha, Rasha T.A. Abdel-Aziz, Noha H. Moftah, et al.. (2020). Cosm-nutraceutical nanovesicles for acne treatment: Physicochemical characterization and exploratory clinical experimentation. International Journal of Pharmaceutics. 577. 119092–119092. 63 indexed citations
6.
Polycarpou, Elena, et al.. (2020). Fluorescein Isothiocyanate Chitosan Nanoparticles in Oral Drug Delivery Studies. Trends in Pharmacological Sciences. 41(10). 686–689. 17 indexed citations
7.
Polycarpou, Elena, et al.. (2020). Biomedical and Pharmacological Uses of Fluorescein Isothiocyanate Chitosan‐Based Nanocarriers. Macromolecular Bioscience. 21(1). e2000312–e2000312. 27 indexed citations
8.
Foot, Peter J.S., et al.. (2020). Overcoming the Blood-Brain Barrier: Functionalised Chitosan Nanocarriers. Pharmaceutics. 12(11). 1013–1013. 74 indexed citations
9.
Bennett, Jason, et al.. (2019). Cocaine addicted to cytoskeletal change and a fibrosis high. Cytoskeleton. 76(2). 177–185. 7 indexed citations
10.
Hassanin, Hany, Ali A. Al-Kinani, Amr ElShaer, et al.. (2017). Stainless steel with tailored porosity using canister-free hot isostatic pressing for improved osseointegration implants. Journal of Materials Chemistry B. 5(47). 9384–9394. 24 indexed citations
11.
Polycarpou, Elena, et al.. (2017). GSTP1 and CYP2B6 Genetic Polymorphisms and the Risk of Bronchopulmonary Dysplasia in Preterm Neonates. American Journal of Perinatology. 34(8). 729–734. 9 indexed citations
12.
Polycarpou, Elena, et al.. (2015). Identification of novel members of the bacterial azoreductase family in Pseudomonas aeruginosa. Biochemical Journal. 473(5). 549–558. 18 indexed citations
13.
Gavrili, Stavroula, et al.. (2015). Association of C609T-Inborn Polymorphism of NAD(P)H: Quinone Oxidoreductase 1 with the Risk of Bronchopulmonary Dysplasia in Preterm Neonates. American Journal of Perinatology. 33(6). 535–539. 7 indexed citations
15.
Polycarpou, Elena, Μαρία Τσολιά, Vasiliki Papaevangelou, et al.. (2013). Enteral L‐Arginine Supplementation for Prevention of Necrotizing Enterocolitis in Very Low Birth Weight Neonates. Journal of Parenteral and Enteral Nutrition. 37(5). 617–622. 44 indexed citations
16.
Polycarpou, Elena, Lisiane B. Meira, Simon Carrington, et al.. (2013). Resveratrol 3‐Od‐glucuronide and resveratrol 4′‐Od‐glucuronide inhibit colon cancer cell growth: Evidence for a role of A3 adenosine receptors, cyclin D1 depletion, and G1 cell cycle arrest. Molecular Nutrition & Food Research. 57(10). 1708–1717. 58 indexed citations
17.
Polycarpou, Elena, et al.. (2013). L-arginine for chronic lung disease (CLD) in preterm neonates. 42. 2056. 1 indexed citations
18.
Polycarpou, Elena, Lambros Lambrinos, & Eftychios Protopapadakis. (2013). Smart parking solutions for urban areas. 1–6. 76 indexed citations
19.
Polycarpou, Elena, et al.. (2012). Oral L-arginine supplementation and faecal calprotectin levels in very low birth weight neonates. Journal of Perinatology. 33(2). 141–146. 3 indexed citations
20.
Polycarpou, Elena, et al.. (2012). The association of NQO1 C609T polymorphism and the susceptibility of bronchopulmonary dysplasia in preterm neonates. 40. 4126. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026